A detailed history of Alaethes Wealth LLC transactions in Dexcom Inc stock. As of the latest transaction made, Alaethes Wealth LLC holds 14,038 shares of DXCM stock, worth $944,476. This represents 0.67% of its overall portfolio holdings.

Number of Shares
14,038
Previous 13,945 0.67%
Holding current value
$944,476
Previous $1.93 Million 17.74%
% of portfolio
0.67%
Previous 0.87%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $10,258 - $13,061
93 Added 0.67%
14,038 $1.59 Million
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $11,422 - $14,010
100 Added 0.72%
13,945 $1.93 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $4,302 - $7,077
57 Added 0.41%
13,845 $1.72 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $42,083 - $67,447
489 Added 3.68%
13,788 $1.29 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $5,623 - $6,548
-50 Reduced 0.37%
13,299 $1.71 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $42,432 - $50,151
408 Added 3.15%
13,349 $1.55 Million
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $2,294 - $3,312
27 Added 0.21%
12,941 $1.47 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $44,893 - $55,377
588 Added 4.77%
12,914 $1.04 Million
Q2 2022

Aug 16, 2022

BUY
$67.99 - $132.89 $644,137 - $1.26 Million
9,474 Added 332.19%
12,326 $919,000
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $29,541 - $40,882
314 Added 12.37%
2,852 $1.46 Million
Q4 2021

Feb 15, 2022

BUY
$129.87 - $162.82 $26,493 - $33,215
204 Added 8.74%
2,538 $1.36 Million
Q3 2021

Nov 16, 2021

SELL
$106.71 - $143.18 $21,342 - $28,636
-200 Reduced 7.89%
2,334 $1.28 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $18,546 - $24,715
229 Added 9.93%
2,534 $1.08 Million
Q1 2021

May 04, 2021

BUY
$84.79 - $104.74 $195,440 - $241,425
2,305 New
2,305 $828,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Alaethes Wealth LLC Portfolio

Follow Alaethes Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaethes Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alaethes Wealth LLC with notifications on news.